Organization | Central South University

Central South University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Changsha China (2000)

Organization Overview

First Clinical Trial

2003

NCT00305474

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Alternative names

2nd hospital of Xiangya medical university | 2nd Xiangya Hospital of Central South University | 3rd Xiangya Hospital, Central South University | Aier Ophthalmology School of Central South University; Shanghai Aier Eye Hospital | Aier School of Ophthalmology, Central South University | Center of New Drug Clinical Trial, Hunan Provincial Tumor Hospital (The Affiliated Tumor Hospital of Xiangya Medical School of Central South University) | Central South University | Central South University Xiangya Hospital | Central South University Xiangya School of Medicine | Central South Unversity | Department of Breast Cancer Medical Oncology | Department of Critical Care Medicine, Xiangya Hospital, Central South University | Department of Dermatology, Second Xiangya Hospital of Central South University, Changsha, China | Department of Otolaryngology, Second Xiangya Hospital, Central South University | Department of PET Center,Xiangya Hospital, Central South University | Department of PET Center,Xiangya Hospital,Central South University | Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, China | Fen Li | HaiNan Province Tumor Hospital | Hunan Cancer Hospital | Hunan Cancer Hospitol | Hunan Provincal Cancer Hospital | Hunan Province Cancer Hospital | Hunan Province Tumor Hospital | Hunan Provincial Cancer Hospital | Hunan Provincial People's Hospital | Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, China | Lingjiang Li | Mental Health Institute of The Second Xiangya Hospital, Central South University | Mental Health Institute, the Second Xiangya Hospital of Central South University | Reproductive and Genetic Hospital of Citic-xiangya | Reproductive & Genetic Hospital of CITIC-Xiangya | Second Xiangya Hospital | Second Xiangya Hospital, Central South University | Second Xiangya Hospital of Central South University | Shanghai Aier Eye Hospital | the Second Xiangya Hospital, Central South University | The Second Xiangya Hospital, Central South University | The Second Xiangya Hospital，Central South University, Changsha, China | The Second Xiangya Hospital, Central South University,China | The Second Xiangya Hospital of Central South Medical University | The second xiangya hospital of central south university, Hunan, China | the second xiangya hospital of CSU | the second xiangya hospitcal | The Second Xianya Hospital of Central South University | The Sencond Xiangya Hospital of Central South University | The Third Xiangya Hospital,Center South University | The third Xiangya Hospital, Central South University | The Third Xiangya Hospital of Central South University | Third Xiangya Hospital of Central South University | wang xiaoyan | Xiangya Boai Rehabilitation Hospital | Xiangya Hospital | Xiangya Hospital Affiliated to Central South University | Xiangya Hospital, Central-South Univercity | Xiangya Hospital, Central South University, Changsha, China | Xiangya Hospital, Central South University, Changsha, Hunan,China,410008 | Xiangya Hospital Central University | Xiangya Hospital of Central South University | Xiangya Hospital of Central South University，Changsha，China | Xiangya Hospital of Central South University, Changsha, Hunan Province | Xiangya Hospital of Centre-South University, Changsha, China | Xiangya hospital of CSU | Xiangyang Central Hospital | Xiangya Second Hospital | Xiangya Second Hospital, Central South University | Yijing He | Yongchang Zhang | Yongchang Zhang, MD | Zhang, Xiao, M.D.

Central South University Report issue

Drugs in Phase 4 Trials (109)

Drugs in Phase 3 Trials (78)

Drugs in Phase 2 Trials (75)

Drugs in Phase 1 Trials (58)

Drugs in Other Trials (65)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview